Abstract | UNLABELLED: RESULTS: The positive rates of C-erbB-2 protein and C-erbB-2 mRNA expression were 87.8%, and 84.0%, respectively in NPC and 74.6% and 76.5%, respectively in PCT. There was a coexpression of C-erbB-2 protein and mRNA. The significant difference for PCNA staining intensity index(S II) existed in the vesico-nuclear and poorly differentiated types of NPC and in the C-erbB-2 staining cases of NPC. No correlation was found between the expression of C-erbB-2 protein and the clinical stage and metastasis as well as survival rate. CONCLUSION: The C-erbB-2 gene overexpression and cell abnormal proliferation are associated with the carcinogenesis and development of NPC. It is helpful to examine both C-erbB-2 gene expression and PCNA in NPC to evaluate the malignant degree and the effect of radiotherapy.
|
Authors | O Jin, Y Yan, M Shen, R Cheng |
Journal | Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University
(Hunan Yi Ke Da Xue Xue Bao)
Vol. 23
Issue 3
Pg. 235-8
( 1998)
ISSN: 1000-5625 [Print] China |
PMID | 10681746
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Proliferating Cell Nuclear Antigen
- RNA, Messenger
- Receptor, ErbB-2
|
Topics |
- Carcinoma, Squamous Cell
(genetics, immunology)
- Cell Division
- Follow-Up Studies
- Humans
- Nasopharyngeal Neoplasms
(genetics, immunology)
- Prognosis
- Proliferating Cell Nuclear Antigen
(analysis)
- RNA, Messenger
(biosynthesis)
- Receptor, ErbB-2
(biosynthesis, genetics)
|